Anpario PLC (ANP.L)
Worksop, GB
Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands. The company's hygiene and insect control category contain products comprising water sanitation tablets, 100% natural insect control powders, and natural drying agents that minimizes the environmental microbial burden, supports the gut health, and animal performance under the Credence, Mitex, and Clean & Dry brands; and toxin management category products consisting of mycotoxin binders under the Anpro brand. It has operations in the Americas, Asia, Europe, the Middle East, and Africa. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +7.69% | +0.90% | +16.67% | +17.89% | +25.14% | +213.73% | -3.45% | +115.38% | +121.34% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+23.5% ★ Q4'25: +55.5% (vs Q4'23)
-
EPS growth Agricultural Inputs: +23.0%+52.0% ★ Q4'25: +183.1% (vs Q4'23)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+11.4% Q4'25: +17.4% (vs Q4'23)
-
EBIT margin Agricultural Inputs: +9.7%+16.7% ★ Q4'25: +18.7% (vs Q4'23)
-
ROIC Agricultural Inputs: +7.4%+23.2% ★ Q4'25: +55.3% (vs Q4'23)
-
Share dilution Agricultural Inputs: +0.0%+5.7% Q4'25: +6.1% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.03× ★ Q4'25: 0.01× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.43M
est: 5.89M (-7.8%)
|
10.96M
est: 10.66M (+2.8%)
|
21.57M
est: 22.84M (-5.6%)
|
19.20M
est: 19.29M (-0.5%)
|
23.51M
est: 23.95M (-1.9%)
|
25.95M
est: 26.39M (-1.7%)
|
23.45M
est: 26.69M (-12.2%)
|
23.32M
est: 23.96M (-2.7%)
|
24.34M
est: 24.48M (-0.6%)
|
29.24M
est: 29.52M (-0.9%)
|
28.28M
est: 28.63M (-1.2%)
|
29.05M
est: 29.05M (0.0%)
|
30.52M
est: 30.50M (+0.1%)
|
33.37M
est: 32.90M (+1.4%)
|
33.10M
est: 33.07M (+0.1%)
|
31.00M
est: 32.72M (-5.3%)
|
38.20M
est: 37.49M (+1.9%)
|
47.18M
est: 47.10M (+0.2%)
|
50.35M
50.00M – 50.60M
+6.9% YoY
|
52.52M
51.95M – 53.10M
+4.3% YoY
|
| EBITDA |
436.0K
est: 1.02M (-57.4%)
|
816.0K
est: 1.82M (-55.1%)
|
1.65M
est: 3.89M (-57.5%)
|
2.18M
est: 1.44M (+50.7%)
|
3.76M
est: 4.08M (-8.0%)
|
3.23M
est: 4.50M (-28.2%)
|
3.39M
est: 4.55M (-25.5%)
|
3.95M
est: 4.17M (-5.3%)
|
3.24M
est: 4.26M (-24.0%)
|
4.23M
est: 5.14M (-17.7%)
|
5.55M
est: 4.14M (+34.1%)
|
5.54M
est: 5.72M (-3.1%)
|
6.59M
est: 5.91M (+11.4%)
|
6.98M
est: 6.23M (+12.0%)
|
4.91M
est: 6.56M (-25.2%)
|
4.00M
est: 5.57M (-28.3%)
|
6.38M
est: 6.38M (0.0%)
|
9.33M
est: 8.02M (+16.4%)
|
8.57M
8.51M – 8.61M
+6.9% YoY
|
8.94M
8.84M – 9.04M
+4.3% YoY
|
| EBIT |
352.0K
est: 803.5K (-56.2%)
|
1.41M
est: 1.43M (-1.1%)
|
1.56M
est: 2.96M (-47.4%)
|
1.88M
est: 2.58M (-27.3%)
|
2.75M
est: 3.21M (-14.2%)
|
2.93M
est: 3.53M (-17.0%)
|
3.05M
est: 3.57M (-14.6%)
|
3.55M
est: 3.27M (+8.5%)
|
2.68M
est: 3.35M (-19.9%)
|
3.99M
est: 4.03M (-1.1%)
|
4.56M
est: 3.26M (+39.9%)
|
4.40M
est: 4.54M (-3.1%)
|
5.36M
est: 4.51M (+18.7%)
|
5.71M
est: 4.76M (+20.0%)
|
3.68M
est: 5.01M (-26.4%)
|
2.76M
est: 4.41M (-37.5%)
|
5.19M
est: 5.05M (+2.6%)
|
7.89M
est: 6.35M (+24.2%)
|
6.79M
6.74M – 6.82M
+6.9% YoY
|
7.08M
7.01M – 7.16M
+4.3% YoY
|
| Net Income |
336.0K
est: 398.9K (-15.8%)
|
1.21M
est: 786.2K (+54.0%)
|
1.28M
est: 1.15M (+11.9%)
|
1.67M
est: 1.44M (+16.1%)
|
2.10M
est: 1.81M (+16.1%)
|
2.56M
est: 2.15M (+18.7%)
|
3.16M
est: 2.31M (+36.9%)
|
3.74M
est: 2.67M (+39.7%)
|
2.58M
est: 2.68M (-3.6%)
|
2.99M
est: 2.83M (+5.3%)
|
4.00M
est: 2.89M (+38.2%)
|
3.72M
est: 4.07M (-8.6%)
|
4.21M
est: 3.90M (+7.8%)
|
4.68M
est: 4.11M (+13.9%)
|
3.30M
est: 4.33M (-23.7%)
|
2.53M
|
4.11M
est: 4.81M (-14.5%)
|
6.75M
est: 6.94M (-2.7%)
|
7.46M
7.17M – 8.00M
+7.5% YoY
|
7.79M
7.48M – 8.33M
+4.4% YoY
|
| SGA |
1.31M
est: 1.89M (-30.5%)
|
1.35M
est: 3.35M (-59.7%)
|
2.60M
est: 5.21M (-50.0%)
|
1.88M
est: 3.57M (-47.4%)
|
4.91M
est: 7.53M (-34.8%)
|
6.02M
est: 8.30M (-27.4%)
|
6.30M
est: 8.39M (-25.0%)
|
6.57M
est: 7.69M (-14.6%)
|
7.51M
est: 7.86M (-4.5%)
|
9.86M
est: 9.48M (+4.0%)
|
9.07M
est: 10.04M (-9.7%)
|
9.21M
est: 9.21M (0.0%)
|
9.88M
est: 10.72M (-7.8%)
|
9.84M
est: 11.30M (-13.0%)
|
9.79M
est: 11.90M (-17.8%)
|
11.44M
est: 10.49M (+9.0%)
|
12.23M
est: 12.02M (+1.8%)
|
15.26M
est: 15.10M (+1.0%)
|
16.14M
16.03M – 16.22M
+6.9% YoY
|
16.84M
16.66M – 17.02M
+4.3% YoY
|
| EPS |
0.03
est: 0.02 (+26.2%)
|
0.08
est: 0.05 (+73.9%)
|
0.07
est: 0.07 (+1.6%)
|
0.09
est: 0.09 (+6.6%)
|
0.12
est: 0.11 (+9.9%)
|
0.14
est: 0.13 (+7.9%)
|
0.16
est: 0.14 (+15.1%)
|
0.17
est: 0.16 (+7.3%)
|
0.13
est: 0.16 (-18.1%)
|
0.15
est: 0.17 (-10.7%)
|
0.19
est: 0.17 (+12.7%)
|
0.18
est: 0.19 (-5.3%)
|
0.21
est: 0.20 (+6.3%)
|
0.23
est: 0.22 (+6.7%)
|
0.16
est: 0.16 (+1.9%)
|
0.14
|
0.25
est: 0.25 (+1.8%)
|
0.40
est: 0.39 (+2.6%)
|
0.42
0.40 – 0.45
+7.5% YoY
|
0.44
0.42 – 0.47
+4.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-28 | A | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-26 | A | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-22 | A | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-21 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-20 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-19 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-18 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-12 | A | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Richard Edwards | Executive Vice Chairman & Chief Executive Officer | 534.0K | male |
| Marc Charles Wilson | Group Finance Director & Director | 365.0K | male |
| Karen L. Prior | Corporate Responsibility Director, Company Secretary & Director | 169.0K | female |
| Pam McLaren | Business Director of Sales | — | female |
| Sarah Osborne | Corporate Development Director | — | female |
| Shane Bailey | Operations Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ANP.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
